Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy

Edward M. Wolin

Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy

Edward M. Wolin

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	11-14
Number of pages	4
Journal	Clinical Advances in Hematology and Oncology
Volume	16
Issue number	9
State	Published - 1 Sep 2018
Externally published	Yes

Cite this

Wolin, Edward M. / Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors : focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy. In: Clinical Advances in Hematology and Oncology. 2018 ; Vol. 16, No. 9. pp. 11-14.

@article{7ef89a2be3374569b61f5c2695afd09e,

title = "Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy",

author = "Wolin, \{Edward M.\}",

year = "2018",

month = sep,

day = "1",

language = "English",

volume = "16",

pages = "11--14",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "9",

}

Wolin, EM 2018, 'Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy', Clinical Advances in Hematology and Oncology, vol. 16, no. 9, pp. 11-14.

Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy. / Wolin, Edward M.
In: Clinical Advances in Hematology and Oncology, Vol. 16, No. 9, 01.09.2018, p. 11-14.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors

T2 - focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy

AU - Wolin, Edward M.

PY - 2018/9/1

Y1 - 2018/9/1

UR - https://www.scopus.com/pages/publications/85062376979

M3 - Article

C2 - 30807563

AN - SCOPUS:85062376979

SN - 1543-0790

VL - 16

SP - 11

EP - 14

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 9

ER -